77 results
8-K
EX-99.1
AFIB
Acutus Medical Inc
11 May 23
Acutus Medical Reports First Quarter 2023 Financial Results
4:03pm
of 2022, reduced by discretionary spend, and the reprioritization of certain research and development programs.
Net loss on a GAAP basis was $16.3 … of products sold
Gross profit
Operating expenses (income):
Research and development
Selling, general and administrative
Goodwill impairment
Restructuring
8-K
EX-99.1
AFIB
Acutus Medical Inc
1 Apr 24
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
4:13pm
expenses.
Operating expenses for continuing operations, consisting of research and development, and selling, general and administrative expenses … expenses resulted from reduced discretionary spend, and the reprioritization of certain research and development programs.
Net loss on continuing
10-Q
2020 Q2
AFIB
Acutus Medical Inc
18 Sep 20
Quarterly report
5:16pm
Costs and operating expenses:
Cost of products sold
Research and development
Selling, general and administrative
Change in fair value of contingent … of the Company’s products.
Research and Development
The Company is actively engaged in new product research and development efforts. Research and development
8-K
EX-99.1
ic4719neyx78
30 Mar 22
Acutus Medical Reports Fourth Quarter and Full Year 2021 Financial Results
4:09pm
8-K
EX-99.1
9xj864u
12 May 21
Acutus Medical Reports First Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
vp7way5uw gfsg2q
7 Aug 23
Acutus Medical Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
yc31uq
8 Nov 23
Acutus Medical Reports Third Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
flyhn0c6v94qjj
18 Mar 21
Acutus Medical Reports Fourth Quarter and Full Year 2020 Financial Results
12:00am
8-K
EX-99.1
riazhsicy3u195w
10 Nov 22
Acutus Medical Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
4i5ddujqw9goe32 1eky
12 Nov 21
Acutus Medical Reports Third Quarter 2021 Financial Results
5:16pm